PriceTargets.com logo

Zymergen - ZY Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: $0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$2.43 As of 11/2/2022 01:00 AM ET
+0 (0.00%)
Get New Zymergen Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for ZY and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for ZY

Analyst Price Target is $0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Zymergen in the last 3 months. The average price target is $0.00, with a high forecast of $0.00 and a low forecast of $10,000,000.00. The average price target represents a -100.00% upside from the last price of $2.43.

This chart shows the closing price for ZY for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 polled investment analysts is to n/a stock in Zymergen. This rating has held steady since July 2023, when it changed from a Hold consensus rating.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 0 sell ratings
Ratings as of
7/5/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/3/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/1/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/31/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
6/29/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
9/27/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
11/26/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
12/26/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
7/26/2022UBS GroupLower Target$2.60
7/26/2022JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral
4/13/2022The Goldman Sachs GroupLower TargetNeutral$6.00 ➝ $4.00
3/24/2022UBS GroupLower TargetNeutral$13.00 ➝ $4.00
3/24/2022The Goldman Sachs GroupLower TargetNeutral$10.50 ➝ $6.00
3/9/2022William BlairReiterated RatingMarket Perform
1/12/2022HSBCUpgradeReduce ➝ Hold$6.50
11/4/2021The Goldman Sachs GroupLower TargetNeutral$12.00 ➝ $10.50
10/15/2021CowenInitiated CoverageMarket Perform
9/27/2021JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$12.00
8/31/2021UBS GroupDowngradeBuy ➝ Neutral$56.00 ➝ $13.00
8/4/2021CitigroupDowngradeBuy ➝ Underperform$43.00 ➝ $7.00
8/4/2021Bank of AmericaDowngradeBuy ➝ Underperform$43.00 ➝ $7.00
8/4/2021HSBCDowngradeHold ➝ Reduce$8.00
8/4/2021JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$12.00
8/4/2021William BlairDowngradeOutperform ➝ Market Perform
8/4/2021The Goldman Sachs GroupDowngradeBuy ➝ Neutral$55.00 ➝ $12.00
8/4/2021CowenDowngradeOutperform ➝ Market Perform
7/6/2021HSBCInitiated CoverageHold$42.00
6/29/2021William BlairInitiated CoverageOutperform
5/17/2021CowenInitiated CoverageOutperform
5/17/2021Bank of AmericaInitiated CoverageBuy$43.00
5/17/2021JPMorgan Chase & Co.Initiated CoverageOverweight$40.00
5/17/2021The Goldman Sachs GroupInitiated CoverageBuy$55.00
(Data available from 12/26/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 1 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
5/30/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
6/29/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
7/29/2024
  • 0 very positive mentions
  • 2 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2024
  • 1 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 1 very negative mentions
Mentions as of
9/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/26/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/26/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Zymergen logo
Zymergen Inc. design, develop, and commercialize microbes, molecules, and materials. It offers an automation solution comprising reconfigurable automation carts, a modular hardware building blocks that allow for assembly of work cells customized for the particular needs of a lab; and automation control software, a cloud-based software used to control integrated automation systems. It serves electronics, packaging, healthcare, agriculture, and other industries. Zymergen Inc. was incorporated in 2013 and is based in Emeryville, California. As of October 19, 2022, Zymergen Inc. operates as a subsidiary of Ginkgo Bioworks Holdings, Inc.
Read More

Today's Range

Now: $2.43
Low: $2.43
High: $2.43

50 Day Range

MA: $2.52
Low: $2.35
High: $3.14

52 Week Range

Now: $2.43
Low: $1.10
High: $12.42

Volume

85 shs

Average Volume

1,229,575 shs

Market Capitalization

$253.58 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.69

Frequently Asked Questions

What sell-side analysts currently cover shares of Zymergen?

The following Wall Street sell-side analysts have issued reports on Zymergen in the last year:
View the latest analyst ratings for ZY.

What is the current price target for Zymergen?

0 Wall Street analysts have set twelve-month price targets for Zymergen in the last year. has the lowest price target set, forecasting a price of $10,000,000.00 for Zymergen in the next year.
View the latest price targets for ZY.

What is the current consensus analyst rating for Zymergen?

Zymergen currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for ZY.

What other companies compete with Zymergen?

Other companies that are similar to Zymergen include OmniAb, MaxCyte, National Research, Absci and Inotiv. Learn More about companies similar to Zymergen.

How do I contact Zymergen's investor relations team?

The company's listed phone number is 415-801-8073 and its investor relations email address is [email protected]. The official website for Zymergen is www.zymergen.com. Learn More about contacing Zymergen investor relations.